SM-04646

N/A

Report date: 2023/01/14 16:58:49
NME

Base Information

Drug NameSM-04646
Drug Alias NameSM-04646
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionWnt signalling pathway inhibitors
TargetsNot applicable
Therapy Area/IndicationsIdiopathic Pulmonary Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNew ZealandAustralia
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBiosplice Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBiosplice Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsIdiopathic Pulmonary Fibrosis

Other Information

ATC CodeN/A
Related LinksN/A